Ophthalmic Drugs Market (By Drug Class Outlook: Antiallergy, Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Agents, Anti-inflammatory [Nonsteroidal Drugs, Steroidal Drugs], Antiglaucoma, Others; By Disease Outlook: Dry Eye [Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments], Allergies [Gels, Eye Solutions, Capsules & Tablets, Eye drops, Ointments], Glaucoma [Gels, Eye Solutions, Capsules & Tablets, Eye drops, Ointments], Inflammation/Infection [Gels, Eye Solutions, Capsules & Tablets, Eye drops, Ointments], Retinal Disorders [Gels, Eye Solutions, Capsules & Tablets, Eye drops, Ointments], Uveitis [Gels, Eye Solutions, Capsules & Tablets, Eye drops, Ointments], Others; By Dosage Form: Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments; By Product Type: Prescription Drugs, OTC Drugs) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
       1.1.1. Definition of Ophthalmic Drugs
       1.1.2. Market Segmentation
       1.1.3. List of Abbreviations
1.2. Summary
       1.2.1. Market Snapshot
       1.2.2. Ophthalmic Drugs Market By Drug Class Outlook
                 1.2.2.1. Global Ophthalmic Drugs Market Revenue and Growth Rate Comparison By Drug Class Outlook (2015-2026)
                 1.2.2.2. Global Ophthalmic Drugs Market Revenue Share By Drug Class Outlook in 2017
                 1.2.2.3. Antiallergy
                 1.2.2.4. Anti-Vascular Endothelial Growth Factor (Anti-Vegf) Agents
                 1.2.2.5. Anti-inflammatory
                              1.2.2.5.1. Nonsteroidal Drugs
                              1.2.2.5.2. Steroidal Drugs
                 1.2.2.6. Antiglaucoma
                 1.2.2.7. Others
       1.2.3. Ophthalmic Drugs Market By Disease Outlook
                 1.2.3.1. Global Ophthalmic Drugs Market Revenue and Growth Rate Comparison By Disease Outlook (2015-2026)
                 1.2.3.2. Global Ophthalmic Drugs Market Revenue Share By Disease Outlook in 2017
                 1.2.3.3. Dry Eye
                 1.2.3.4. Allergies
                 1.2.3.5. Glaucoma
                 1.2.3.6. Inflammation/Infection
                 1.2.3.7. Retinal Disorders
                 1.2.3.8. Uveitis
                 1.2.3.9. Others
       1.2.4. Ophthalmic Drugs Market By Dosage Form
                 1.2.4.1. Global Ophthalmic Drugs Market Revenue and Growth Rate Comparison By Dosage Form (2015-2026)
                 1.2.4.2. Global Ophthalmic Drugs Market Revenue Share By Dosage Form in 2017
                 1.2.4.3. Gels
                 1.2.4.4. Eye Solutions
                 1.2.4.5. Capsules & Tablets
                 1.2.4.6. Eye Drops
                 1.2.4.7. Ointments
                 1.2.4.8. Others
       1.2.5. Ophthalmic Drugs Market By Product Type
                 1.2.5.1. Global Ophthalmic Drugs Market Revenue and Growth Rate Comparison By Product Type (2015-2026)
                 1.2.5.2. Global Ophthalmic Drugs Market Revenue Share By Product Type in 2017
                 1.2.5.3. Prescription Drugs
                 1.2.5.4. OTC Drugs
                 1.2.5.5. Others
       1.2.6. Ophthalmic Drugs Market by Geography
                 1.2.6.1. Global Ophthalmic Drugs Market Revenue and Growth Rate Comparison by Geography (2015-2026)
                 1.2.6.2. North America Ophthalmic Drugs Market Revenue and Growth Rate (2015-2026)
                 1.2.6.3. Europe Ophthalmic Drugs Market Revenue and Growth Rate (2015-2026)
                 1.2.6.4. Asia-Pacific Ophthalmic Drugs Market Revenue and Growth Rate (2015-2026)
                 1.2.6.5. Latin America Ophthalmic Drugs Market Revenue and Growth Rate (2015-2026)
                 1.2.6.6. Middle East and Africa (MEA) Ophthalmic Drugs Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
       2.4.1. Bargaining Power of Suppliers
       2.4.2. Bargaining Power of Buyers
       2.4.3. Threat of Substitute
       2.4.4. Threat of New Entrants
       2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
       2.6.1. Raw Material and Suppliers
       2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
       2.8.1. Player Positioning Analysis
       2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Ophthalmic Drugs Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Ophthalmic Drugs Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Ophthalmic Drugs Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Ophthalmic Drugs Major Manufacturers in 2017

CHAPTER 4. Ophthalmic Drugs Market By Drug Class Outlook

4.1. Global Ophthalmic Drugs Revenue By Drug Class Outlook
4.2. Antiallergy
       4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Anti-Vascular Endothelial Growth Factor (Anti-Vegf) Agents
       4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Anti-inflammatory
       4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
       4.4.3. Nonsteroidal Drugs
       4.4.4. Steroidal Drugs
4.5. Antiglaucoma
       4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
       4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. Ophthalmic Drugs Market By Disease Outlook

5.1. Global Ophthalmic Drugs Revenue By Disease Outlook
5.2. Dry Eye
       5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Allergies
       5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Glaucoma
       5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Inflammation/Infection
       5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Retinal Disorders
       5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. Uveitis
       5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.8. Others
       5.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. Ophthalmic Drugs Market By Dosage Form

6.1. Global Ophthalmic Drugs Revenue By Dosage Form
6.2. Gels
       6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Eye Solutions
       6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Capsules & Tablets
       6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Eye Drops
       6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Ointments
       6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.7. Others
       6.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. Ophthalmic Drugs Market By Product Type

7.1. Global Ophthalmic Drugs Revenue By Product Type
7.2. Prescription Drugs
       7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. OTC Drugs
       7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Others
       7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. North America Ophthalmic Drugs Market By Country

8.1. North America Ophthalmic Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America Ophthalmic Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
       8.3.1. U.S. Ophthalmic Drugs Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
       8.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.4. Canada
       8.4.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
       8.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.5. Mexico
       8.5.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
       8.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 9. Europe Ophthalmic Drugs Market By Country

9.1. Europe Ophthalmic Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe Ophthalmic Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
       9.3.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
       9.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.4. Germany
       9.4.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
       9.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.5. France
       9.5.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
       9.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.6. Spain
       9.6.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
       9.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.7. Rest of Europe
       9.7.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
       9.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 10. Asia-Pacific Ophthalmic Drugs Market By Country

10.1. Asia-Pacific Ophthalmic Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific Ophthalmic Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
         10.3.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         10.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.4. Japan
         10.4.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         10.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.5. India
         10.5.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         10.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.6. Australia
         10.6.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         10.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.7. South Korea
         10.7.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         10.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
         10.8.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         10.8.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 11. Latin America Ophthalmic Drugs Market By Country

11.1. Latin America Ophthalmic Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America Ophthalmic Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
         11.3.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         11.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.4. Argentina
         11.4.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         11.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.5. Rest of Latin America
         11.5.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         11.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 12. Middle East Ophthalmic Drugs Market By Country

12.1. Middle East Ophthalmic Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East Ophthalmic Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. Saudi Arabia
         12.3.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         12.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
12.4. UAE
         12.4.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         12.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
12.5. Rest of Middle East
         12.5.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         12.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 13. Africa Ophthalmic Drugs Market By Country

13.1. Africa Ophthalmic Drugs Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Africa Ophthalmic Drugs Market Revenue Share Comparison, 2015 & 2026 (%)
13.3. South Africa
         13.3.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         13.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
13.4. Egypt
         13.4.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         13.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
13.5. Rest of Africa
         13.5.1. Market Revenue and Forecast By Drug Class Outlook, 2015 - 2026 ($Million)
         13.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 14. COMPANY PROFILE

14.1. Allergan Plc
         14.1.1. Company Snapshot
         14.1.2. Overview
         14.1.3. Financial Overview
         14.1.4. Product Portfolio
         14.1.5. Key Developments
         14.1.6. Strategies
14.2. Pfizer, Inc.
         14.2.1. Company Snapshot
         14.2.2. Overview
         14.2.3. Financial Overview
         14.2.4. Product Portfolio
         14.2.5. Key Developments
         14.2.6. Strategies
14.3. Santen Pharmaceutical Co., Ltd.
         14.3.1. Company Snapshot
         14.3.2. Overview
         14.3.3. Financial Overview
         14.3.4. Product Portfolio
         14.3.5. Key Developments
         14.3.6. Strategies
14.4. Johnson & Jean - Services, Inc.
         14.4.1. Company Snapshot
         14.4.2. Overview
         14.4.3. Financial Overview
         14.4.4. Product Portfolio
         14.4.5. Key Developments
         14.4.6. Strategies
14.5. Merck Sharp & Dohme Corp.
         14.5.1. Company Snapshot
         14.5.2. Overview
         14.5.3. Financial Overview
         14.5.4. Product Portfolio
         14.5.5. Key Developments
         14.5.6. Strategies
14.6. Genentech, Inc. AG
         14.6.1. Company Snapshot
         14.6.2. Overview
         14.6.3. Financial Overview
         14.6.4. Product Portfolio
         14.6.5. Key Developments
         14.6.6. Strategies
14.7. Bausch & Lomb, Inc.
         14.7.1. Company Snapshot
         14.7.2. Overview
         14.7.3. Financial Overview
         14.7.4. Product Portfolio
         14.7.5. Key Developments
         14.7.6. Strategies
14.8. Regeneron Pharmaceutical, Inc.
         14.8.1. Company Snapshot
         14.8.2. Overview
         14.8.3. Financial Overview
         14.8.4. Product Portfolio
         14.8.5. Key Developments
         14.8.6. Strategies
14.9. Others
         14.9.1. Company Snapshot
         14.9.2. Overview
         14.9.3. Financial Overview
         14.9.4. Product Portfolio
         14.9.5. Key Developments
         14.9.6. Strategies

CHAPTER 15. RESEARCH APPROACH

15.1. Research Methodology
         15.1.1. Initial Data Search
         15.1.2. Secondary Research
         15.1.3. Primary Research
15.2. Assumptions and Scope


Cart Summary